Carlos Van Hemelrijck

Carlos Van Hemelrijck is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications for pain management. His work is characterized by a focus on improving the efficacy and safety of drug delivery systems.

Latest Patents

Carlos holds a patent for a stable formulation for parenteral administration of tapentadol. This invention relates to an aqueous pharmaceutical composition that includes Tapentadol or a physiologically acceptable salt thereof. The concentration of Tapentadol in the composition ranges from 0.10 to 8.00 mg/mL, based on the weight of Tapentadol free base and the total volume of the composition. The pH value of the composition is buffered and maintained within the range of 4.0 to 6.0. This formulation is particularly useful for treating acute pain, especially in pediatric patients. Additionally, the invention encompasses a container for the pharmaceutical composition and a process for its preparation, as well as a kit that includes the container in appropriate packaging.

Career Highlights

Carlos is associated with Grünenthal GmbH, a company known for its commitment to developing innovative pain management solutions. His work at Grünenthal has allowed him to focus on creating effective pharmaceutical formulations that address the needs of patients suffering from pain.

Collaborations

Throughout his career, Carlos has collaborated with esteemed colleagues such as Ulrich Reinhold and Marc Schiller. These collaborations have contributed to the advancement of research and development in the pharmaceutical industry.

Conclusion

Carlos Van Hemelrijck's innovative work in pharmaceutical formulations exemplifies the importance of research in improving patient care. His contributions, particularly in the area of pain management, highlight the potential for advancements in medical treatments.

Profile summary based on public USPTO records.